Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:law
|
| gptkbp:beganIn |
late 1990s
|
| gptkbp:cause |
health risks
pulmonary hypertension heart valve disease |
| gptkbp:containsSettlement |
over $13 billion
|
| gptkbp:drugWithdrawn |
1997
|
| gptkbp:FDAInvolvement |
FDA requested withdrawal
|
| gptkbp:impact |
gptkb:drug
mass tort litigation |
| gptkbp:involves |
gptkb:Wyeth
gptkb:American_Home_Products |
| gptkbp:jurisdiction |
gptkb:United_States
|
| gptkbp:mediaCoverage |
extensive
|
| gptkbp:notablePlaintiffAttorney |
gptkb:Michael_D._Hausfeld
Arnold Levin |
| gptkbp:relatedTo |
Fen-Phen
diet drugs |
| gptkbp:resultedIn |
class action lawsuits
settlements withdrawal of Fen-Phen from market |
| gptkbp:bfsParent |
gptkb:John_O'Quinn
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
Fen-Phen litigation
|